|
Ethiopia
The Joint Programme support in Ethiopia reinforced primary healthcare and community-led HIV prevention and treatment efforts for key and vulnerable populations, including sex workers, prisoners, and people who inject drugs. Comprehensive HIV prevention, care and treatment guidelines were updated to integrate the latest WHO recommendations, including strategies for co-management of HIV, Leishmaniasis and cryptococcal meningitis (WHO).
The Government adopted long-acting injectable cabotegravir (CAB-LA) and included pregnant and lactating mothers and people who inject drugs in the national PrEP programme. The national post-exposure prophylaxis (PEP) now covers non-medically exposed people in addition to medical and occupational rape cases. Heightened advocacy further led to the inclusion of people who inject drugs as among the key populations that are particularly vulnerable to HIV in Ethiopia and the development of tailored HIV programme for this group (UNICEF, WHO, UNAIDS Secretariat). Similarly, the National HIV and AIDS Strategic Plan 2023-2027 identified people with high-risk disabilities, unhoused children and adults and people in humanitarian settings as priority populations (UNAIDS Secretariat).